BlackRock, Inc. 13D and 13G filings for Blueprint Medicines Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-23 8:19 pm Sale | 2025-03-31 | 13G | BLUEPRINT MEDICINES CORP COM BPMC | BlackRock Inc. BLK | 5,090,723 8.000% | -1,493,453 (-22.68%) | Filing |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | BLUEPRINT MEDICINES CORP COM BPMC | BlackRock Inc. BLK | 6,584,176 10.800% | 309,654 (+4.94%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | BLUEPRINT MEDICINES CORP COM BPMC | BlackRock Inc. BLK | 6,274,522 10.500% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | BLUEPRINT MEDICINES CORP COM BPMC | BlackRock Inc. BLK | 6,274,522 10.500% | 281,919 (+4.70%) | Filing |
| 2022-11-09 3:21 pm Purchase | 2022-10-31 | 13G | BLUEPRINT MEDICINES CORP COM BPMC | BlackRock Inc. BLK | 5,992,603 10.000% | 655,729 (+12.29%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | BLUEPRINT MEDICINES CORP COM BPMC | BlackRock Inc. BLK | 5,336,874 9.100% | 280,711 (+5.55%) | Filing |